XERS
Xeris Pharmaceuticals Inc
10.50$
+2.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -67.1% | +59.6% | -69.9% | +174.7% | -43.7% | +211.4% | -28.9% | +37.6% | -69.0% | +29.0% | +0.9% | +477.1% | -4.1% | +13.4% | +366.1% | -24.1% | +14.3% | +8.7% | +23.9% | +96.4% | +1.9% | +14.6% | +17.5% | +11.5% | +0.2% | +14.5% | +27.1% | -8.1% | -8.5% | +18.3% | +12.9% | +10.7% | +0.0% | +19.0% | +4.0% | +15.4% | -3.1% | +10.8% | – | |
| – | -65.0% | -99.9% | +192,150.0% | +25.1% | -99.6% | +31,085.7% | +18.5% | -99.7% | -100.0% | – | -56.5% | +15,930.0% | +11.7% | -27.4% | +118.0% | +20.3% | -46.4% | +85.3% | -4.8% | +51.8% | +28.3% | -23.3% | +9.4% | +19.6% | -15.5% | +42.0% | +8.6% | +25.4% | -41.9% | +75.8% | +29.5% | -30.3% | -7.9% | +67.4% | -24.7% | +73.5% | -30.4% | -5.8% | – | |
| – | -66.8% | +58.5% | -69.7% | +174.7% | -52.7% | +270.6% | -28.9% | +30.4% | -67.3% | +19.8% | +5.4% | -16.6% | -100.8% | – | +808.8% | -43.1% | +69.2% | -13.3% | +41.5% | +114.7% | -5.8% | +29.7% | +19.4% | +9.8% | +3.8% | +9.2% | +31.7% | -15.0% | +1.6% | +8.4% | +8.3% | +24.5% | +1.5% | +10.8% | +11.3% | +5.3% | +4.7% | +14.0% | – | |
| – | -64.2% | +14.7% | +36.3% | +14.9% | +32.4% | -0.4% | +25.3% | +13.9% | +6.3% | +46.8% | -19.7% | -20.0% | -46.5% | -20.4% | -26.7% | +31.8% | -21.1% | +33.5% | +5.2% | +78.0% | -38.0% | -40.5% | +62.5% | -18.0% | -2.4% | +25.8% | -17.3% | +26.8% | +22.5% | -26.4% | +2.2% | +3.5% | +27.3% | +3.9% | -7.1% | +5.2% | +11.5% | +21.5% | – | |
| – | -67.0% | +16.3% | +29.4% | +53.6% | +4.6% | +38.9% | +3.4% | +87.6% | +43.5% | +20.0% | -1.0% | +38.8% | +4.7% | -18.3% | -6.6% | +9.2% | +0.0% | +44.1% | +2.3% | +104.2% | -33.7% | -8.2% | +4.6% | -0.4% | -2.2% | +12.0% | -0.9% | +0.8% | +2.2% | +4.2% | +12.4% | -10.7% | +9.7% | +0.9% | +4.7% | +2.2% | +11.9% | +14.8% | – | |
| – | -65.0% | +15.1% | +34.4% | +25.0% | +23.5% | +10.3% | +17.8% | +36.0% | +21.6% | +33.8% | -11.5% | +8.8% | -14.5% | -18.8% | -11.2% | +13.5% | +0.0% | +35.5% | +2.8% | +102.2% | -31.0% | -12.2% | +9.7% | -2.8% | -2.1% | +12.8% | -3.0% | -2.4% | +11.3% | -6.5% | +17.1% | -8.6% | +11.3% | -3.7% | +8.0% | -11.8% | +24.0% | +20.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -284.0% | – | +50.2% | +149.2% | -52.8% | -34.7% | – | |
| – | -50.0% | +0.0% | +19,100.0% | -99.5% | +19,000.0% | +194.2% | +31.1% | +43.1% | +0.8% | -0.1% | +230.2% | -56.3% | -2.1% | +49.6% | +3.8% | +97.2% | -61.0% | +0.2% | +0.2% | -0.1% | +96.0% | -2.1% | +15.7% | +9.5% | +42.3% | +5.0% | +4.9% | +2.5% | +0.2% | +13.3% | -2.2% | -1.1% | -5.2% | +0.7% | -1.2% | -1.6% | -3.8% | +0.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,684.4% | -79.8% | -1,492.2% | – | |
| – | – | – | +4,400.0% | -100.0% | – | +153.4% | +52.3% | +19.5% | +20.7% | -0.1% | +230.2% | -113.1% | – | -109.3% | – | +113.1% | -56.8% | +0.2% | +0.2% | -0.1% | -122.7% | – | – | – | – | -124.5% | – | – | – | +144.0% | -543.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,684.4% | -79.8% | -1,492.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -78.5% | +599.8% | +28.9% | +27.5% | -12.7% | -269.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.